Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 08, 2024

Risk of 30-Day All-Cause Readmission in Patients With ILD After COVID-19

Annals of the American Thoracic Society


Additional Info

Annals of the American Thoracic Society
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data
Ann Am Thorac Soc 2024 Mar 01;21(3)428-437, A Vaeli Zadeh, R Dinparastisaleh, A Vaezi, D Bandyopadhyay, I Rubinstein, HZ Baig, R Calderon-Candelario, A Hashemi Shahraki, T Kawasaki, JM Magnusson, LO Larsson, A Sharafkhaneh, JD Herazo-Maya, AS Lee, M Mirsaeidi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading